Fatty liver may signal hidden heart danger

NCT ID NCT04774302

Completed Knowledge-focused Sponsor: Clinique Pasteur Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study examined 292 people with non-alcoholic fatty liver disease (NAFLD) to see if liver scarring is linked to heart disease risk. Researchers used non-invasive tests like the coronary calcium score and liver elastography. The goal was to better understand how to screen for heart problems in this high-risk group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better identify NAFLD patients who are at high risk for heart disease, leading to earlier prevention.
What could go wrong: This is an observational study, not a treatment trial. It only looks for connections, so it won't directly improve health. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NAFLD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver metabolic dysfunction-associated steatotic liver disease metabolic syndrome X

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NAFLD

Contacts and locations

Locations

Clinique Pasteur

Toulouse, 31 076, France
Hôpital St Joseph

Marseille, 13285, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.